Login / Signup

Prediction of PSA Response after Dexamethasone Switch during Abiraterone Acetate + Prednisolone Treatment of Metastatic Castration-Resistant Prostate Cancer Patients.

Bertalan FeketeKrisztina BiróFruzsina GyergyayNándor PolkOrsolya HorváthLajos GécziAttila PatocsBarna Budai
Published in: Cancers (2024)
A high accuracy model was developed for mCRPC patients in predicting cases which might benefit from the switch. For non-responders, induction of the next systemic treatment is indicated.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • prostate cancer
  • small cell lung cancer
  • peritoneal dialysis
  • prognostic factors
  • radical prostatectomy